Inhibition of cell motility by troglitazone in human ovarian carcinoma cell line

BACKGROUND: Troglitazone (TGZ) is a potential anticancer agent. Little is known about the effect of this agent on cancer cell migration. METHODS: Human ovarian carcinoma cell line, ES-2 cells were treated with various concentrations of TGZ. Cell migration was evaluated by wound-healing and Boyden ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yuh-Cheng, Ho, Tsung-Chuan, Chen, Show-Li, Lai, Huei-Yi, Wu, Ju-Yun, Tsao, Yeou-Ping
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2233635/
https://www.ncbi.nlm.nih.gov/pubmed/18021457
http://dx.doi.org/10.1186/1471-2407-7-216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2233635/
https://www.ncbi.nlm.nih.gov/pubmed/18021457
http://dx.doi.org/10.1186/1471-2407-7-216

Ejemplares similares